Literature DB >> 6213193

In vitro activity of moxalactam alone and in combination with penicillin against common meningeal pathogens.

P H Azimi, M G Dunphy.   

Abstract

Moxalactam demonstrated marked activity against beta-lactamase-positive and -negative Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis by both standard minimal inhibitory concentration testing and growth curve studies. Moxalactam was ineffective against S. pneumoniae partially susceptible to penicillin G. Moxalactam (5 micrograms/ml) and penicillin (1 microgram/ml) in combination were indifferent to each other's antibacterial activity, exerting neither synergism nor antagonism against these organisms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213193      PMCID: PMC181929          DOI: 10.1128/AAC.21.3.521

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Prevalence of ampicillin- and chloramphenicol-resistant strains of Haemophilus influenzae causing meningitis and bacteremia: national survey of hospital laboratories.

Authors:  J I Ward; T F Tsai; G A Filice; D W Fraser
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

Review 2.  The current status of chloramphenicol.

Authors:  H C Meissner; A L Smith
Journal:  Pediatrics       Date:  1979-09       Impact factor: 7.124

3.  Chloramphenicol resistance in Haemophilus influenzae.

Authors:  A Manten; B van Klingeren; M Dessens-Kroon
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

4.  Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens.

Authors:  J J Rahal; M S Simberkoff
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

5.  Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935).

Authors:  C S Cordera; R S Pekarek
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

6.  Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.

Authors:  R R Bulger; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin.

Authors:  E O Mason; S L Kaplan; D C Anderson; D B Hinds; R D Feigin
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

8.  Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol.

Authors:  J F Kenny; C D Isburg; R H Michaels
Journal:  Pediatrics       Date:  1980-07       Impact factor: 7.124

9.  Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.

Authors:  S L Kaplan; E O Mason; H Garcia; S J Kvernland; E M Loiselle; D C Anderson; A A Mintz; R D Feigin
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

10.  Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.

Authors:  U B Schaad; G H McCracken; N Threlkeld; M L Thomas
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

View more
  1 in total

Review 1.  Cephalosporins in gram-positive infections.

Authors:  J Symonds; A M Geddes
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.